K200595

Substantially Equivalent

CellaVision DC-1, CellaVision DC-1 PPA

Applicant: CellaVision AB
Product code: JOY
Advisory panel: Hematology
Date received: 2020-03-06
Decision date: 2020-10-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Lund, SE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.